Sabry M Attia Selected Research

5-aminoisoquinolinone

2/2021	5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism.
1/2020	5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T+ Itpr3tf/J mouse model for autism.
2/2015	The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.
8/2014	Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabry M Attia Research Topics

Disease

34	Autistic Disorder (Autism) 05/2022 - 12/2016
32	Inflammation (Inflammations) 10/2021 - 09/2013
22	Neoplasms (Cancer) 12/2022 - 03/2008
9	Arthritis (Polyarthritis) 03/2021 - 09/2013
8	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 06/2007
8	Neuroinflammatory Diseases 01/2020 - 12/2016
6	Experimental Arthritis 03/2021 - 09/2013
6	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2020 - 09/2015
6	Rheumatoid Arthritis 01/2020 - 06/2014
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2022 - 03/2014
5	Asthma (Bronchial Asthma) 10/2019 - 05/2016
5	Acute Lung Injury 03/2019 - 02/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 12/2016
4	Nervous System Diseases (Neurological Disorders) 01/2019 - 10/2017
4	Pneumonia (Pneumonitis) 11/2015 - 04/2014
4	Hypertension (High Blood Pressure) 01/2014 - 04/2013
3	Leukemia 04/2022 - 09/2013
3	Autism Spectrum Disorder 01/2022 - 06/2020
3	Cardiotoxicity 11/2017 - 09/2014
3	Edema (Dropsy) 10/2016 - 06/2014
3	Hepatocellular Carcinoma (Hepatoma) 05/2016 - 04/2014
3	Pleurisy (Pleuritis) 04/2015 - 04/2014
3	Necrosis 07/2014 - 09/2013
3	Aneuploidy (Aneuploid) 01/2012 - 03/2008
2	Acute Kidney Injury (Acute Renal Failure) 10/2021 - 01/2021
2	Colitis 01/2020 - 03/2014
2	Carcinogenesis 01/2020 - 01/2019
2	Liver Neoplasms (Liver Cancer) 01/2016 - 01/2015
2	Breast Neoplasms (Breast Cancer) 01/2016 - 09/2014

Drug/Important Bio-Agent (IBA)

26	CytokinesIBA 01/2022 - 04/2013
13	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2014
13	Interleukin-17 (Interleukin 17)IBA 10/2021 - 04/2014
9	AntioxidantsIBA 02/2021 - 07/2008
7	Chemokine ReceptorsIBA 01/2022 - 12/2016
6	Pharmaceutical PreparationsIBA 12/2022 - 05/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2013
6	Proteins (Proteins, Gene)FDA Link 07/2020 - 09/2015
6	Imiquimod (Aldara)FDA LinkGeneric 06/2020 - 09/2015
5	3-nitrotyrosineIBA 10/2021 - 05/2016
5	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2018 - 01/2017
5	CarrageenanIBA 11/2015 - 04/2014
4	phthalic acid (phthalate)IBA 05/2022 - 12/2020
4	5-aminoisoquinolinoneIBA 02/2021 - 08/2014
4	EnzymesIBA 02/2021 - 02/2012
4	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2021 - 03/2017
4	Oxidants (Oxidizing Agents)IBA 02/2021 - 01/2019
4	GlucocorticoidsIBA 07/2020 - 09/2013
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 10/2016
4	ChemokinesIBA 05/2019 - 03/2014
4	Peroxidase (Myeloperoxidase)IBA 03/2019 - 09/2015
4	ResveratrolIBA 01/2018 - 01/2012
4	Dexrazoxane (Zinecard)FDA LinkGeneric 11/2017 - 09/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 11/2010
4	AntipyreticsIBA 01/2014 - 04/2013
3	Interleukin-9 (Interleukin 9)IBA 03/2021 - 10/2017
3	Diethylhexyl Phthalate (DEHP)IBA 02/2021 - 12/2020
3	Phosphotransferases (Kinase)IBA 01/2021 - 10/2019
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 10/2019
3	N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA 07/2020 - 12/2019
3	ibrutinibIBA 06/2020 - 10/2019
3	TyrphostinsIBA 01/2020 - 10/2016
3	AG 127 (AG 126)IBA 01/2020 - 10/2016
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 10/2016
3	AllergensIBA 10/2019 - 01/2018
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 05/2016
3	AnthracyclinesIBA 11/2017 - 01/2016
3	Histamine (Histamine Dihydrochloride)FDA Link 07/2015 - 06/2014
3	naringinIBA 04/2015 - 11/2008
3	Messenger RNA (mRNA)IBA 01/2015 - 06/2014
3	DNA ProbesIBA 06/2013 - 10/2011
2	Interleukin-10 (Interleukin 10)IBA 10/2021 - 02/2021
2	Therapeutic UsesIBA 02/2021 - 10/2019
2	Lipid PeroxidesIBA 02/2021 - 05/2016
2	Environmental Pollutants (Pollutants, Environmental)IBA 02/2021 - 01/2021
2	PlasticizersIBA 01/2021 - 12/2020
2	3-aminobenzamideIBA 12/2020 - 03/2014
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2020 - 11/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019 - 01/2018
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2017 - 10/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2017 - 01/2017
2	CadmiumIBA 04/2017 - 06/2014
2	Caspase 3 (Caspase-3)IBA 04/2017 - 02/2012
2	STA-21IBA 01/2017 - 01/2017
2	Collagen Type II (Type II Collagen)IBA 01/2017 - 06/2014
2	IonomycinIBA 01/2017 - 01/2017
2	LipopolysaccharidesIBA 01/2017 - 05/2016
2	CollagenIBA 01/2017 - 06/2014
2	ChitosanIBA 01/2017 - 01/2016
2	phorbol-12-myristateIBA 01/2017 - 01/2017
2	thymoquinoneIBA 05/2016 - 04/2014
2	Interleukin-8 (Interleukin 8)IBA 05/2016 - 04/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2015 - 10/2013
2	Poly (ADP-Ribose) Polymerase-1IBA 02/2015 - 08/2014
2	4-methylhistamineIBA 07/2014 - 06/2014
2	proanthocyanidinIBA 04/2014 - 09/2013
2	Etoposide (VP 16)FDA LinkGeneric 09/2013 - 09/2009
2	Amsacrine (AMSA)IBA 06/2013 - 03/2008
2	NocodazoleIBA 06/2013 - 03/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 09/2015
4	Traditional Medicine (Folk Remedies) 01/2014 - 04/2013